• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

SpectraCure AB Quarterly Report (1 July to 30 September) 2019

SpectraCure
Read the release
Third quarter (1 July - 30 September 2019)
  • Other income amounted to TSEK 692 (215).
  • Profit after tax amounted to TSEK -3 054 (-1 922).
  • Corresponding to SEK -0,04 (-0,03) kr per share before and after diluted earnings.
  • Operating cash flow was TSEK -3 072 (-2 640).
  • Cash as of 30 September amounted to TSEK 25 421 (2 185) TSEK.
  • Equity ratio: 81 (85)%.
Third quarter (1 January - 30 June 2019) 
  • Other income amounted to TSEK 2 005 (902).
  • Profit after tax amounted to TSEK -9 979 (-8 572).
  • Corresponding to SEK -0,12 (-0,13) kr per share before and after diluted earnings.
  • Operating cash flow was TSEK -6 648 (-7 058).